// App-Quantinova.ai

P363 : TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA DURING COVID-19

Researchers

Presenter

  • Evgeniya Paramonova

Principal Investigators

  • Elena Misyurina

  • Elena Baryakh

  • Ekaterina Karimova

  • Ekaterina Zotina

  • Ekaterina Grishina

  • Diana Gagloeva

Medical Centers

  • hematology,Moscow city hospital №52,Moscow,Россия

  • hematology,Moscow city hospital №52,Moscow,Россия

  • hematology,Moscow city hospital №52,Moscow,Россия

  • heamatology,Moscow City Clinical Hospital 52,Moscow,Russia

  • heamatology,Moscow City Clinical Hospital 52,Moscow,Russia

Locations

  • United States

  • Russia

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Coronavirus disease

  • B-cell acute lymphoblastic leukemia

  • T-cell acute lymphoblastic leukemia

Biomarkers

  • N/A

Drug/Treatment

  • Glucocorticoid

  • Interleukin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved